341 related articles for article (PubMed ID: 29254385)
1. Development of self-microemulsifying drug delivery system for oral delivery of poorly water-soluble nutraceuticals.
Shah AV; Desai HH; Thool P; Dalrymple D; Serajuddin ATM
Drug Dev Ind Pharm; 2018 Jun; 44(6):895-901. PubMed ID: 29254385
[TBL] [Abstract][Full Text] [Related]
2. Effect of different polysorbates on development of self-microemulsifying drug delivery systems using medium chain lipids.
Shah A; Thool P; Sorathiya K; Prajapati H; Dalrymple D; Serajuddin ATM
Drug Dev Ind Pharm; 2018 Feb; 44(2):215-223. PubMed ID: 29057677
[TBL] [Abstract][Full Text] [Related]
3. Mixed lipid phase SMEDDS as an innovative approach to enhance resveratrol solubility.
Bolko K; Zvonar A; Gašperlin M
Drug Dev Ind Pharm; 2014 Jan; 40(1):102-9. PubMed ID: 23301796
[TBL] [Abstract][Full Text] [Related]
4. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
[TBL] [Abstract][Full Text] [Related]
5. A comparative evaluation of mono-, di- and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development.
Prajapati HN; Dalrymple DM; Serajuddin AT
Pharm Res; 2012 Jan; 29(1):285-305. PubMed ID: 21861203
[TBL] [Abstract][Full Text] [Related]
6. Development of self-microemulsifying lipid-based formulations of
Aloisio C; Shah AV; Longhi M; Serajuddin ATM
Drug Dev Ind Pharm; 2021 Jun; 47(6):897-907. PubMed ID: 34033503
[TBL] [Abstract][Full Text] [Related]
7. Self-microemulsifying smaller molecular volume oil (Capmul MCM) using non-ionic surfactants: a delivery system for poorly water-soluble drug.
Bandivadeka MM; Pancholi SS; Kaul-Ghanekar R; Choudhari A; Koppikar S
Drug Dev Ind Pharm; 2012 Jul; 38(7):883-92. PubMed ID: 22087760
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
Grove M; Müllertz A; Nielsen JL; Pedersen GP
Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
[TBL] [Abstract][Full Text] [Related]
9. Formulation of self-microemulsifying drug delivery system (SMEDDS) by D-optimal mixture design to enhance the oral bioavailability of a new cathepsin K inhibitor (HL235).
Visetvichaporn V; Kim KH; Jung K; Cho YS; Kim DD
Int J Pharm; 2020 Jan; 573():118772. PubMed ID: 31765770
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of critical formulation parameters in design and differentiation of self-microemulsifying drug delivery systems (SMEDDSs) for oral delivery of aciclovir.
Janković J; Djekic L; Dobričić V; Primorac M
Int J Pharm; 2016 Jan; 497(1-2):301-11. PubMed ID: 26611669
[TBL] [Abstract][Full Text] [Related]
11. A self-microemulsifying drug delivery system to overcome intestinal resveratrol toxicity and presystemic metabolism.
Seljak KB; Berginc K; Trontelj J; Zvonar A; Kristl A; Gašperlin M
J Pharm Sci; 2014 Nov; 103(11):3491-3500. PubMed ID: 25103361
[TBL] [Abstract][Full Text] [Related]
12. Development and optimization of a self-microemulsifying drug delivery system for atorvastatin calcium by using D-optimal mixture design.
Yeom DW; Song YS; Kim SR; Lee SG; Kang MH; Lee S; Choi YW
Int J Nanomedicine; 2015; 10():3865-77. PubMed ID: 26089663
[TBL] [Abstract][Full Text] [Related]
13. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS.
Woo JS; Kim TS; Park JH; Chi SC
Arch Pharm Res; 2007 Jan; 30(1):82-9. PubMed ID: 17328246
[TBL] [Abstract][Full Text] [Related]
14. Characterization and evaluation of solid self-microemulsifying drug delivery systems with porous carriers as systems for improved carbamazepine release.
Milović M; Djuriš J; Djekić L; Vasiljević D; Ibrić S
Int J Pharm; 2012 Oct; 436(1-2):58-65. PubMed ID: 22721847
[TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin.
Hintzen F; Perera G; Hauptstein S; Müller C; Laffleur F; Bernkop-Schnürch A
Int J Pharm; 2014 Sep; 472(1-2):20-6. PubMed ID: 24879935
[TBL] [Abstract][Full Text] [Related]
16. In vitro/in silico approach in the development of simvastatin-loaded self-microemulsifying drug delivery systems.
Ćetković Z; Cvijić S; Vasiljević D
Drug Dev Ind Pharm; 2018 May; 44(5):849-860. PubMed ID: 29228833
[TBL] [Abstract][Full Text] [Related]
17. Quality-by-design based development of a self-microemulsifying drug delivery system to reduce the effect of food on Nelfinavir mesylate.
Kamboj S; Rana V
Int J Pharm; 2016 Mar; 501(1-2):311-25. PubMed ID: 26854426
[TBL] [Abstract][Full Text] [Related]
18. Formulation optimization and pharmacokinetics evaluation of oral self-microemulsifying drug delivery system for poorly water soluble drug cinacalcet and no food effect.
Cao M; Xue X; Pei X; Qian Y; Liu L; Ren L; Chen G
Drug Dev Ind Pharm; 2018 Jun; 44(6):969-981. PubMed ID: 29313395
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
Fei Y; Kostewicz ES; Sheu MT; Dressman JB
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
[TBL] [Abstract][Full Text] [Related]
20. Solid self microemulsification of Atorvastatin using hydrophilic carriers: a design.
Nanda Kishore R; Yalavarthi PR; Vadlamudi HC; Vandana KR; Rasheed A; Sushma M
Drug Dev Ind Pharm; 2015; 41(7):1213-22. PubMed ID: 25019500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
